Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Immix Biopharma, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 12 | 18 | +6 |
| Shares | 400.8K | 656.1K | +255.3K (+63.7%) |
| Value | $729.8K | $1.75M | +$1.02M (+139.4%) |
New holders (9)
Institutions that held Immix Biopharma, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lynwood Capital Management Inc. | 200,250 | $538.7K | 0.68% |
| Koshinski Asset Management, Inc. | 51,001 | $137.2K | 0.01% |
| Commonwealth Equity Services, LLC | 22,825 | $61.0K | 0.00% |
| Imprint Wealth LLC | 22,280 | $42.3K | 0.03% |
| BlackRock Inc. | 15,648 | $42.1K | 0.00% |
| Dimensional Fund Advisors LP | 11,911 | $32.0K | 0.00% |
| Renaissance Technologies LLC | 10,600 | $29.0K | 0.00% |
| Parallel Advisors, LLC | 2,890 | $7.77K | 0.00% |
| Tortoise Investment Management, LLC | 1,000 | $2.69K | 0.00% |
Sold out (3)
Institutions that held Immix Biopharma, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 17,723 | $32.3K |
| Ground Swell Capital, LLC | 10,692 | $19.5K |
| UBS Group AG | 2,301 | $4.19K |